Well that answers my previous question as to whether they have enough cash to do ph2 trials - they do now!
Not sure whether management participation is kosher, as the price they paid is approx 20% less (3.8c vs 4.5c) than shareholders who participated in recent rights issue. Interesting !
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
12.3¢ |
Change
-0.008(5.77%) |
Mkt cap ! $10.37M | |||
| Open | High | Low | Value | Volume |
| 12.5¢ | 13.0¢ | 12.0¢ | $16.79K | 134.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 84491 | 12.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.5¢ | 5 | 1 |
View Market Depth
| Last trade - 13.11pm 24/06/2025 (20 minute delay) ? |
| IVX (ASX) Chart |